Peptide record

TPDB87451

CREKA Selfassembly modified_plain modified
5 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB87451
CREKA
Selfassembly
Self-assembling and biomaterial peptides
MedChemExpress Peptipedia
modified_plain
Yes
A 5-aa modified selfassembly peptide sequence curated from MedChemExpress and Peptipedia, with an available 3D structural model.
Modified, details unspecified
Sequence
CREKA acetate
Physicochemical Analysis
C50H86N16O21S2
NDQGHILMFPSWYV
AE
1311.45
4.55
2
3
3
-1
7.15
-0.762
23.08
Mammalian: 1.2 hour Yeast: >20 hour E.coli: >10 hour
125
9.53
4
Residue Composition
number
3
A
1
R
0
N
0
D
2
C
3
E
0
Q
0
G
0
H
0
I
0
L
1
K
0
M
0
F
0
P
0
S
2
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 3 R: 1 N: 0 D: 0 C: 2 E: 3 Q: 0 G: 0 H: 0 I: 0 L: 0 K: 1 M: 0 F: 0 P: 0 S: 0 T: 2 W: 0 Y: 0 V: 0
Chemical Descriptors
5
C50H86N16O21S2
1311.45
4.55
-1
7.15
-0.762
Self-Assembly Information 1 records
Record 1 MedChemExpress

Source

Self-assembling peptides product page

Self-Assembly

Nanostructure formation
Nanofibers
Physiological conditions
Selfassembly; Nanostructure=Nanofibers; Trigger=Physiological conditions
Product/source page describes self-assembly into functional nanostructures
Tumor targeting fibrin-targeted nanostructure
drug carrier
MedChemExpress
Selfassembly
Evidence Records 1 records
Evidence 1 Selfassembly

Activity

Nanostructure formation
Selfassembly Nanostructure=Nanofibers Trigger=Physiological conditions
Nanofibers

Source & Reference

NA
MedChemExpress

Other

Acetate salt
Tumor targeting fibrin-targeted nanostructure
drug carrier
Physiological conditions
Product/source page describes self-assembly into functional nanostructures
Self-assembling peptides product page
Lower-confidence seed row verify primary literature before import.
Additional Detail Fields 6 fields
Physiological conditions
Acetate salt
Lower-confidence seed row verify primary literature before import.
Self-assembling peptides product page
Tumor targeting fibrin-targeted nanostructure
drug carrier